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Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions
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Greg Kaluza1
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Background: In bifurcations, 2-stent strategy is usually associated with higher restenosis
rate than a 1-stent strategy (provisional stenting).
Methods: 15 ovine coronary bifurcations received main vessel Cypher stents and then
were allocated to group T (n8; T-stenting of the side branch with Cypher) or group P
(n7; PTCA of the side branch). At 180 days, the proximal, carina and distal segments
of the bifurcation underwent radiographic and histologic evaluation.
Results: All morphometric and qualitative data were comparable between groups at the
proximal and distal sections. At the carina section, group T showed a significantly greater
degree of neointimal growth (5.061.42 mm2 versus 2.210.69 mm2, p0.001) and
percent area stenosis (51.413.3% versus 31.17.2%, p0.004) compared with group P.
Both inflammation score (1.140.48 versus 0.360.38, p0.005) and fibrin deposition
(14.668.17% versus 0.792.10%, p0.001) were significantly higher in group T.
Granulomas and giant cells were observed in group T but absent in group P. Stent fracture
was more prevalent (87.5% vs. 28.6%, p0.05) and severe (multiple fracture: 87.5% vs.
14.3%, p0.01; major fracture: 62.5% vs. 0%, p0.05) in group T than group P, mostly
involving the connectors at the side branches. Neointimal eccentricity was insignificantly
higher in group T than group P (0.940.06 versus 0.890.12, p0.45).
Conclusions: Compared with balloon angioplasty, side branch T-stenting induced more
neointimal growth which was likely related to higher incidence of fractures, persistent
inflammation and fibrin deposition.
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First-in-man (FIM) study of dedicated bifurcation sirolimus-eluting stent
BiOSS (Bifurcation Optimization Stent System) Lim - 9 months results
Robert Gil1, Dobrin Vassilev2, Imre Ungi3, Jacek Bil1
1Central Clinical Hospital of the Ministry of Internal Affairs and Administration,
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Background: The best treatment strategy for a coronary bifurcation stenosis is still
unknown. However, dedicated bifurcation stents are the most promising solution. The
BiOSS® Lim is a dedicated coronary bifurcation balloon expanding stent made of 316L
stainless steel releasing sirolimus from the surface of a biodegradable coating comprised
of copolymer of lactic and glycolic acid. The polymer releases sirolimus in a time-
controlled process lasting ca 8 weeks. The stent consists of two parts with different
diameters connected with two 1.5-mm bridges. The BiOSS stent is mounted on a
dedicated bifurcation balloon (Bottle®, Balton, Poland) with markers of proximal and
distal stent edges and third marker at the mid part showing the proximal end of its smaller
distal part. The stent delivery is a rapid exchange system.
Methods: 35 patients with stable CAD were included into the prospective, feasibility and
safety assessment registry. The patients with STEMI or Medina type 001 bifurcation
lesions were excluded. The primary end-points of the study were MACEs (in-hospital and
after 1, 3, 6, 12 months). An angiographic control was planned at 9 months in all patients.
Provisional T-stenting was the obligatory strategy. A double antiplatelet therapy was
applied for at least 6 months. Here are presented results up to the 3rd month, however at
the time of TCT 2012 9 months data will be available.
Results: The average age of enrolled patients (67% males) was 6910 years. 18 (51.4%)
patients had hypertension, 8 (22.8%) were diabetic, 7 (20%) had a history of prior PCI and
3 (8.6%) patients had previous CABG. The dominant vessel was LAD (40%) followed by
LMS (34.3%), LCx (17.1%) and RCA (8.6%). The true bifurcation was present in 68.6%.
All BiOSS® stents were implanted successfully (avg. pressure 14atm), without any
periprocedural complication. There were only 5 (14.3%) cases with second stent
implanted in the side branch. There were 2 (5.7%) MI type 4a. At one and three months
all patients were uneventful.
Conclusions: The dedicated bifurcation BiOSS® Lim stent is a feasible device with
promising safety and short-term clinical effectiveness. Long-term data are pending.
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Background: Coronary bifurcations are frequently encountered in contemporary inter-
ventional practice and clinical outcomes are in general inferior when compared to
non-bifurcation lesions. Therefore, our aim was to study the short and long-term safety
and performance of the Nobori® drug-eluting stent in this lesion subset.
Methods: NOBORI 2 and eNOBORI are two large, prospective, single-arm, multi-centre
registries that enrolled 3067 and 7750 patients respectively, out of which 728 and 616 had
at least 1 bifurcation lesion treated (BFL). In NOBORI 2, all bifurcations were included
and all adverse events were adjudicated by an independent clinical event committee, while
in eNOBORI, only true bifurcations were considered and adjudication is ongoing
(including stent thrombosis). The primary endpoint was Target Lesion Failure (TLF)
defined as composite of cardiac death (CD), target vessel related myocardial infarction
(TV-MI) and target lesion revascularization (TLR). We report short and long term results
of patients with BFL compared to patients without BFL treated (NBFL).
Results: In the BFL group, the number of treated lesions was higher (2.41.5 vs
2.01.6; p0.001), more complex (B2/C: 73% vs 54%; p0.001) and more frequently
ostial (21.1% vs 11.1%; p0.001) and located in the LAD (55.0% vs 43.6%) and LM
(5.1% vs 1.6%) than in NBFL group. TV-MI (2.1% vs 0.3%) and TLF (2.5% vs 0.7%)
rates were higher in the BFL group at 1 month follow-up. In the cohort followed-up to
3-year, TV-MI (3.2% vs 2.1%) and TLR (4.4% vs 3.1%), results remained similar
between the groups while cardiac death rate was significantly lower in BFL group (0.8%
vs 2.7%, p0.01). TLF was comparable at 3-year (6.7% vs 6.4%), with a very low
number of definite and probable stent thrombosis in both subgroups (0.7% vs 0.9%).
Conclusions: Good short and long-term clinical outcomes with a low rate of TLF and
stent thrombosis indicate that Nobori® Biolimus A9 eluting stent, with its specific open
cell design and biodegradable polymer, is safe and highly effective for the treatment of
challenging bifurcation lesions, despite their complexity and frequent localization in left
main coronary artery.
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Background: Recent studies did not support mandatory performing of final kissing
ballooning (FKB) after main vessel (MV) stenting. We sought to investigate the impact
of FKB on stent expansion, apposition, and neointimal hyperplasia in coronary bifurcation
lesions treated with 1-stent technique.
Methods: Postprocedural and 9-month follow-up intravascular ultrasound (IVUS)
images were studied in 94 bifurcation lesions treated by MV stenting with FKB (FKB
group) and in 68 bifurcation lesions treated by MV stenting only (non-FKB group).
Analysis included 4 distinct locations, namely, MV proximal stent, MV carina (between
the most proximal part of the carina and5 mm distal to the carina in the MV stent), MV
distal stent, and side branch (SB) ostium (5 mm distal to the carina).
Results: Postprocedural minimum stent area (MSA) of the MV and stent expansion were not
significantly different in both groups (6.12.1 mm2 versus 5.71.6 mm2, p0.11, and
98.123.8% versus 96.629.1%, p0.72, respectively). Inadequate stent apposition tended
to be found less frequently in the FKB group than in the non-FKB group (3.2% versus 10.3%,
p0.09). At follow-up, minimum lumen area of the MV was not significantly different
between the 2 groups (5.32.2 mm2 versus 5.01.6 mm2, p0.26). No significant
differences in the percent neointimal area were observed between the 2 groups.
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Conclusions: Serial IVUS analyses suggest that FKB may improve stent apposition
without impact on stent expansion and neointimal hyperplasia in bifurcation lesions
treated with 1-stent technique.
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Background: The Sideguard® (Cappella) stent is a self-expanding nitinol stent specif-
ically designed with a flaring cap for treatment of bifurcation lesions. Aim of this registry
study is to assess the safety and clinical efficacy of this novel stent in treating bifurcation
lesions in a real world setting.
Methods: Since June 2010 a dedicated eCRF registry has been used to collect data on all
patients undergoing PCI with the Sideguard stent in the 36 participating European centres.
Data collected include Patient demographics, PCI procedure and clinical follow-up up to
1 yr. Clinical end point studied includes death, myocardial infarction (MI) and target
lesion revascularisation (TLR). Secondary endpoints included procedure time, fluoros-
copy time, contrast volume, procedural success and device success. The study is on-going
and to date complete data up to discharge is available in 320 patients and is reported here.
Results: Mean age was 6510.6 and 247(77%) were male and 18% were diabetic.
Bifurcation site was in LAD in 71%, CX in 18%, RCA in 3% and Left Main in 8%.
Medina classification was 1:1:1 in 69%, 1:0:1 in 8%, 0:1:1 in 15%. Calcification was
present in 28% of the cases. Mean main vessel diameter was 3.33mm0.44mm, mean
vessel stent length was 22.3mm7.05mm Mean side branch (SB) vessel diameter was
2.75mm0.3mm and mean SB vessel lesion length was 8.9 5.9. In 12% cases a second
DES stent was used in the SB distal to Sideguard stent. Final kissing balloon was
attempted in 52% cases and was successful in all cases. TIMI flow pre-procedure was
TIMI 3 in 80% of cases and 99% post-procedure. From the entire cohort there was a
10.6% procedural failure and a 3.7% device failure as defined by the protocol. MACE was
3.1% of 320, 6.7% of 254 & 11.2% of 107 patients at 30 days, 6 and 12 months
respectively. Total stent thrombosis rate was 1.2%.
Conclusions: In this on-going registry study, the data to date shows that Sideguard®
stent can be used to treat complex bifurcation lesions successfully with a very low
procedural complication. Follow up clinical outcome also remains favorable though more
data is required which should be available at the time of presentation.
TCT-691
The Feasibility And Safety Of Balloon Dilation Over The Jailed Wire To
Reopen The (sub)Occluded Side Branch During Provisional Stenting
li chengxiang1, yuan ming1
1xijing hospital, Xian, Shaan’xi
Background: To evaluate the feasibility and safety of balloon dilation over the jailed
wire (BDJW) to re-open (sub) totally occluded side branch during provisional stenting for
bifurcation lesions.
Methods: There were 23 bifurcation lesions (4 in right coronary artery, 19 in left anterior
artery) in 23 cases with abrupt (sub) total occlusion of side branch (SB) after stent implantation
in main branch (MB). The mean age was 63.1 years old (range 51-78) and 77% were male.
BDJW was used as a bailout technique after failure of multiple rewiring attempts. Once the
small balloon (1.25-1.5 mm) has successfully entered the SB ostium under the MB stent struts,
it was inflated to reopen the SB, and another guidewire was rewired from the true lumen of
MB to SB. A routine manoeuvre for bifurcation was then applied and final correcting the MB
stent distortion should be done by redilation of the proximal MB stent struts.
Results: The percentage rate of success was 87% (20/23) and no seriously compromises
like death, acute myocardial infarction, or stent thrombosis occurred during hosptalization.
Small balloon could not be advanced into SB ostium over jailed wire in 3 pts although
balloon anchor and other techniques were used. Two of 5 (40%) pts with stent segment
length 10mm proximal to SB ostium were successfully treated compared to all of 18
(100%, P0.05) pts with that10mm. During a short follow-up period (8.2 months,
range 2-24), there was no further seriously compromises or repeat revascularization.
Conclusions: BDJW can be used as a bailout technique to facilitate rewiring with a 87%
success rate in case of (sub) total SB occlusion during provisional stenting. Stent segment
length 10mm proximal to SB ostium was associated with a lower success rate of this
technique.
TCT-692
Impact of Treatment Strategy on Clinical Outcomes Differs Between Patients
with Left Main and those with Non-Left Main Bifurcation Lesions
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Joo-Yong Hahn1, Sang Hoon Lee1, Jeong Hoon Yang2
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Background: We sought to investigate whether impact of bifurcation technique (1-
versus 2-stent techniques) on clinical outcomes differed between patients with left main
(LM) bifurcation lesion and those with non-LM bifurcation lesion.
Methods: A total of 2897 patients who received percutaneous coronary intervention for
bifurcation lesions were enrolled from 18 centers in Korea between January 2003 and
January 2010. Inclusion criteria: 1) coronary bifurcation lesions treated solely with
drug-eluting stent and 2) a main vessel diameter of2.5 mm and side branch diameter of
2.3 mm. The exclusion criteria were: 1) cardiogenic shock and 2) cardiopulmonary
resuscitation before index procedure. Primary outcome was cardiac death or MI.
Secondary outcome was target lesion failure (TLF) including cardiac death, myocardial
infarction (MI), and target lesion revascularization.
Results: The median follow-up duration was 36 months. Among 2044 patients with
non-LM bifurcation lesion, 1618 underwent 1-stent technique and 426 underwent 2-stent
technique. The 2-stent group was more likely to have extensive coronary artery stenosis.
After propensity-score matching, treatment with 2-stent technique was associated with a
higher incidence of TLF (HR 1.59; 95% CI 1.13-2.24; p0.01), but not of cardiac death
(HR 0.95; 95% CI 0.32-2.85; p0.93) and cardiac death or MI (HR 1.49; 95% CI
0.80-2.80; p0.21). Among 853 patients with LM bifurcation lesions, 509 underwent
1-stent technique and 344 underwent 2-stent technique. After propensity-score matching,
patients with 2-stent technique had a higher incidence of cardiac death (HR 2.66; 95% CI
1.10-6.40; p0.02), cardiac death or MI (HR 2.31; 95% CI 1.21-4.42; p0.01) as well as
TLF (HR 3.08; 95% CI 2.04-4.64; p0.01).
Conclusions: Compared with 1-stent technique, 2-stent technique was associated with a
higher incidence of cardiac death or MI in patients with LM bifurcation lesion, but not in
those with non-LM bifurcation lesion.
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Impact of the syntax score on the outcome of the left main after drug-eluting
stent implantation
Klaus Tiroch1,, Julinda Mehilli2,, Lars Bansemir1,, Melchior Seyfarth3,,
Adnan Kastrati2
1HELIOS Klinkum, Wuppertal, Germany, 2N/A, Munich, Germany, 3HELIOS
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Background: There is a debate regarding the long term results for unprotected left main
bifurcation disease (uLMCA) depending on the SYNTAX score.
Methods: This analysis is based on a randomized study of 607 patients with symptomatic
coronary artery disease undergoing PCI for uLMCA. 302 were assigned to receive a PES
and 305 assigned to receive a SES. We evaluated the prognostic impact of the syntax
score on the angiographic restenosis rate (ISR) and the need of target lesion revasculari-
sation (TLR) for the left main itself.
Results: The 3-year resuts showed a mortality rate of 5,8% and a TLR rate of 12,5%. 235
(39%) had a true bifurcation lesion (TBL, Medina 1,1,1), associated with a higher need for
multiple stents (60% vs. 19%, P0.001), with culotte-stenting in 78% and T-stenting in
22% of cases. From the overall population of 607 patients, 204 (34%) had SYNTAX
scores 22, 234 (39%) had scores 23-32, and 169 (28%) had scores 33. For the 235
patients with TBL, the distribution was different from the overall population with 15 (6%),
102 (44%), and 118 (50%), P0.001. Angiographic restenosis rates did not differ between
the three categories (14% for scores 22, 19% for scores 23-32, 20% for scores 33,
P0.15). The need for repeat revascularization was similar for the three categories (13%,
19% and 12%, respectively, P0.54).
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